Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:46:08 EDT Fri 27 Jun 2025
Enter Symbol
or Name
USA
CA



Q:PLSE - PULSE BIOSCIENCES INC - https://investors.pulsebiosciences.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PLSE - Q0.114.43·17.160.115.08+0.191.3222.53,2182,86914.94  15.34  14.7625.00  9.9116:34:42May 2315 min RT 2¢

Recent Trades - Last 10 of 2869
Time ETExPriceChangeVolume
16:34:42Q15.080.193
16:29:16Q15.08030.19034,354
16:18:47Q15.080.19202
16:18:47Q15.080.19202
16:18:47Q15.080.1941
16:13:25Q15.08030.1903138
16:11:40Q15.080.19144
16:06:14Q15.080.19179
16:05:09Q15.080.19200
16:05:08Q15.080.191,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-05-23 16:05U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-05-08 16:05U:PLSENews ReleasePulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results
2025-05-06 16:05U:PLSENews ReleasePulse Biosciences To Present at the BofA Securities 2025 Health Care Conference
2025-05-01 07:00U:PLSENews ReleasePulse Biosciences' Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting
2025-04-25 16:05U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-04-24 16:05U:PLSENews ReleasePulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025
2025-04-23 07:00U:PLSENews ReleasePulse Biosciences' Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting
2025-03-27 16:05U:PLSENews ReleasePulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results
2025-03-26 16:05U:PLSENews ReleasePulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference
2025-03-07 08:00U:PLSENews ReleasePulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025
2025-03-04 08:00U:PLSENews ReleasePulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-02-20 16:05U:PLSENews ReleasePulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
2025-02-04 08:00U:PLSENews ReleasePulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
2025-01-30 08:00U:PLSENews ReleasePulse Biosciences' Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting
2025-01-21 07:00U:PLSENews ReleasePulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360degree Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium
2025-01-13 07:00U:PLSENews ReleasePulse Biosciences' Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium
2025-01-10 08:00U:PLSENews ReleasePulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
2025-01-03 09:00U:PLSENews ReleasePulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference
2024-12-23 16:30U:PLSENews ReleasePulse Biosciences, Inc. Announces Planned Redemption of Warrants
2024-12-19 08:00U:PLSENews ReleasePulse Biosciences, Inc. Announces Election to Exercise Company Warrants